Villarreal-Ríos E, Medrano-Navarro DM; Vargas-Daza ER, Galicia-Rodríguez L, Martínez-González L, Márquez-Solano JC

Language: Spanish
References: 20
Page: 460-466
PDF size: 220.12 Kb.

ABSTRACT

Background: In the literature it has been pointed out that the prevalence of anemia in patients with frailty is 52% and it has been observed that the risk of acquiring frailty increases when amount of hemoglobin is lower.
Objective: To determine the association between mild normocytic anemia and frailty syndrome in geriatric patients.
Material and Method: A comparative cross-sectional study was done from October to December 2018 with patients older than 60 years of age. The study group was divided into two groups. Group 1: patients with mild normocytic anemia. Group 2: patients without anemia. Anemia was diagnosed based on the World Health Organization classification of hemoglobin levels. Frailty was based on the criteria proposed by Linda Fried and then modified by Avila Funes.
Results: The size of the sample was of 49 patients per group. The study identified an association between anemia and frailty syndrome; 70% of patients diagnosed with anemia also had frailty syndrome and 48% of patients without anemia also had it (p = 0.04). The group of robust/pre-frail patients when compared with frail patients identified an association statistically significant with anemia (p = 0.03 and RM = 2.52). The probability of developing frailty based on lower hemoglobin levels lesser than 13.5 was greater than 50%.
Conclusion: This study demonstrated an association between anemia and frailty syndrome.

REFERENCES

1. Carrazco-Peña KB, Farías-Moreno K, Trujillo-Hernández B. Frecuencia de envejecimiento exitoso y fragilidad. Factores de riesgo asociados. Revista Española de Geriatría y Gerontología 2018; 53(Issue 1): 23-25. https://doi.org/10.1016/j. regg.2017.05.011

2. Cascio MJ, DeLoughery TG. Anemia: Evaluation and diagnostic tests. Pathology. Med Clin North Am 2017; 101(Issue 2): 263-284. http://dx.doi.org/10.1016/j. mcna.2016.09.003

3. Brugnara C, Mohandas N. Red cell indices in classification and treatment of anemia: from M.M. Wintrobe's original 1934 classification to the third millennium. Curr Opin Hematol 2013; 20(3): 223-230. DOI: 10.1097/ MOH.0b013e32835f5933

4. Zilinski J, Zillmann R, Becker I, Benzing T, Schulz R, Röhrig G. Prevalence of anemia among elderly inpatients and its association with multidimensional loss of function. Ann Hematology 2014; 93(10): 1645-1654. DOI: 10.1007/ s00277-014-2110-4

5. Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: Does hemoglobin change with aging? Semin Hematol 2015; 52(Issue 4): 261-269. https:// doi.org/10.1053/j.seminhematol.2015.07.006

6. Gómez S, Remacha AF, Muñoz M. Anemia del anciano. Medicina Clínica, 2017; 149(11): 496-503. DOI: 10.1016/j. medcli.2017.06.025

7. Romero-Ruperto S, Pérez-Bocanegra MC, Durán-Taberna M, Toscano-Rivera A, Barbé-Gil Ortega J, San José-Laporte A. Prevalencia y valor pronóstico al año de la anemia en pacientes ingresados en una unidad geriátrica de agudos. Rev Esp Geriatr Gerontol 2015; 50(3): 122-125. DOI: 10.1016/j.regg.2014.09.002

8. Sieber CC. Frailty-from concept to clinical practice. Experimental Gerontology 2016; 87(Pt B): 160-167. DOI: 10.1016/j.exger.2016.05.004

9. Carrazco-Peña KB, Frías-Moreno K, Trujillo-Hernández B. Frecuencia de envejecimiento exitoso y fragilidad. Factores de riesgo asociados. Revista Española de Geriatría y Gerontología 2018; 53(1): 23-5. https://doi.org/10.1016/j.regg.2017.05.011

10. Conroy S, Elliott A. The frailty syndrome. Medicine 2017; 45(Issue 1): 15-18. https://doi.org/10.1016/j.mpmed. 2016.10.010

11. Andrés E, Serraj K, Federici L, Vogel T, Kaltenbach G. Anemia in elderly patients: New insight into an old disorder. Geriatr Gerontol Int 2012; 13(Issue 3): 519-527. DOI: 10.1111/ggi.12017

12. Ávila-Funes JA, Helmer C, Amieva H, Barberger-Gateau P, Le M, Ritchie K, et al. Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med ScI 2008; 63(10): 1089-1096.

13. Juárez-Cedillo T, Basurto-Acevedo L, Vega-García S, Manuel-Apolinar L, Cruz-Tesoro E, Rodríguez-Pérez J, et al. Prevalence of anemia and its impact on the state of frailty in elderly people living in the community: SADEM study. Ann Hematol 2014; 93(12): 2057-2062. DOI: 10.1007/ s00277-014-2155-4

14. Röhring G, Klossok W, Becker I, Benzing T, Schulz RJ. Prevalence of anemia among elderly patients in an emergency room setting. Eur Geriatr Med 2014; 5(Issue 1): 3-7. http:// dx.doi.org/10.1016/j.eurger.2013.10.008

15. Ekerstad N, Bylin K, Karlson BW. Early rehospitalizations of frail elderly patients -the role of medications: a clinical, prospective, observational trial. Drug Healthc Patient Saf 2017; 9: 77-88. https://dx.doi.org/10.2147%2FDHPS. S139237

16. Aguilar-Navarro SG, Amieva H, Gutiérrez-Robledo LM, Avila-Funes JA. Frailty among Mexican community-dwelling elderly: a story told 11 years later. The Mexican health and aging study. Salud Publica Mex 2015; 57(01): S62-S69.

17. Hirani V, Naganathan V, Blyth F, Le Couteur DG, Kelly P, Handelsman DJ, et al. Cross-sectional and longitudinal associations between anemia and frailty in older Australian men: The concord health and aging in men project. JAMDA 2015; 16(Issue7): 614-620. http://dx.doi.org/10.1016/j. jamda.2015.02.014

18. Röhrig G. Anemia in the frail, elderly patient. Clin Interv Aging 2016; 11: 319-326. doi: 10.2147/CIA.S90727

19. Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol 2008; 45(4): 250-254. doi: 10.1053/j.seminhematol.2008.06.003

20. Artz AS, Thirman MJ. Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic. J Gerontol A Biol Sci Med Sci 2011; 66A(8): 925-932. doi: 10.1093/ gerona/glr090